Ablynx NV (XBRU:ABLXS) Interest Expense : €-7.43 Mil (TTM As of Dec. 2017)

View and export this data going back to . Start your Free Trial

What is Ablynx NV Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ablynx NV's interest expense for the six months ended in Dec. 2017 was € -3.74 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2017 was €-7.43 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ablynx NV's Operating Income for the six months ended in Dec. 2017 was € -28.98 Mil. Ablynx NV's Interest Expense for the six months ended in Dec. 2017 was € -3.74 Mil. Ablynx NV did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ablynx NV Interest Expense Historical Data

The historical data trend for Ablynx NV's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV Interest Expense Chart

Ablynx NV Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.09

-4.07

-7.11

-7.43

Ablynx NV Semi-Annual Data
	Dec07	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17
Interest Expense	Get a 7-Day Free Trial															4.77	-3.54	-3.57	-3.69	-3.74

Ablynx NV Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2017 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-7.43 Mil.

Ablynx NV (XBRU:ABLXS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ablynx NV's Interest Expense for the six months ended in Dec. 2017 was €-3.74 Mil. Its Operating Income for the six months ended in Dec. 2017 was €-28.98 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2017 was €88.72 Mil.

Ablynx NV's Interest Coverage for the quarter that ended in Dec. 2017 is calculated as

Ablynx NV did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Ablynx NV (XBRU:ABLXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.ablynx.com

Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines